Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course
Blastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-05-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/431033 |
id |
doaj-8a4b280194b24ce79d036942b9bf7079 |
---|---|
record_format |
Article |
spelling |
doaj-8a4b280194b24ce79d036942b9bf70792020-11-24T23:18:43ZengKarger PublishersCase Reports in Dermatology1662-65672015-05-017210711210.1159/000431033431033Blastomycosis and Pregnancy: An Unusual Postpartum Disease CourseDavid SurprenantMonika KaniszewskaKelli HutchensChristine GoPaul O'KeefeJames SwanRebecca TungBlastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The partial immunosuppressive state induced by pregnancy can engender more severe infections and is associated with a risk of vertical transmission. Published cases describe postpartum symptomatic improvement accompanying immune reconstitution, even in the absence of treatment. We present a 31-year-old gravid female with multifocal cutaneous blastomycosis. After delivering a healthy full-term infant with no evidence of congenital infection, the patient's cutaneous lesions continued to worsen. At 6 weeks postpartum she was treated with oral itraconazole and demonstrated clinical improvement after 5 months of therapy. This case highlights the importance of prompt disease recognition, understanding of risk factors and initiation of appropriate antifungal therapy of blastomycotic infection occurring in the unique setting of pregnancy.http://www.karger.com/Article/FullText/431033BlastomycosisCutaneousPregnancy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David Surprenant Monika Kaniszewska Kelli Hutchens Christine Go Paul O'Keefe James Swan Rebecca Tung |
spellingShingle |
David Surprenant Monika Kaniszewska Kelli Hutchens Christine Go Paul O'Keefe James Swan Rebecca Tung Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course Case Reports in Dermatology Blastomycosis Cutaneous Pregnancy |
author_facet |
David Surprenant Monika Kaniszewska Kelli Hutchens Christine Go Paul O'Keefe James Swan Rebecca Tung |
author_sort |
David Surprenant |
title |
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course |
title_short |
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course |
title_full |
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course |
title_fullStr |
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course |
title_full_unstemmed |
Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course |
title_sort |
blastomycosis and pregnancy: an unusual postpartum disease course |
publisher |
Karger Publishers |
series |
Case Reports in Dermatology |
issn |
1662-6567 |
publishDate |
2015-05-01 |
description |
Blastomyces dermatitidis is responsible for systemic mycoses. It is predominantly caused by inhalation of spores and often manifests as pneumonia, which can potentially disseminate; however, direct cutaneous inoculation may also occur. Blastomycosis in the perigravid period is exceedingly rare. The partial immunosuppressive state induced by pregnancy can engender more severe infections and is associated with a risk of vertical transmission. Published cases describe postpartum symptomatic improvement accompanying immune reconstitution, even in the absence of treatment. We present a 31-year-old gravid female with multifocal cutaneous blastomycosis. After delivering a healthy full-term infant with no evidence of congenital infection, the patient's cutaneous lesions continued to worsen. At 6 weeks postpartum she was treated with oral itraconazole and demonstrated clinical improvement after 5 months of therapy. This case highlights the importance of prompt disease recognition, understanding of risk factors and initiation of appropriate antifungal therapy of blastomycotic infection occurring in the unique setting of pregnancy. |
topic |
Blastomycosis Cutaneous Pregnancy |
url |
http://www.karger.com/Article/FullText/431033 |
work_keys_str_mv |
AT davidsurprenant blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT monikakaniszewska blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT kellihutchens blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT christinego blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT paulokeefe blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT jamesswan blastomycosisandpregnancyanunusualpostpartumdiseasecourse AT rebeccatung blastomycosisandpregnancyanunusualpostpartumdiseasecourse |
_version_ |
1725580404893679616 |